Literature DB >> 9184941

Antiherpetic and anticoagulant properties of carrageenans from the red seaweed Gigartina skottsbergii and their cyclized derivatives: correlation between structure and biological activity.

M J Carlucci1, C A Pujol, M Ciancia, M D Noseda, M C Matulewicz, E B Damonte, A S Cerezo.   

Abstract

The antiviral activity against herpes simplex virus types 1 and 2 of kappa/l-, partially cyclized mu/v-, and lambda-carrageenans isolated from the red seaweed Gigartina skottsbergii and their cyclized derivatives was analyzed. lambda-Carrageenans and the partially cyclized mu/v-carrageenan were the most potent inhibitors of herpes viruses (including acyclovir-resistant variants and clinical isolates), with IC50 values lower than 1 microgram ml-1 against both serotypes and selectivity indices higher than 10(3). kappa/l-Carrageenans were slightly less effective than the other two types with IC50 values in the range 1.6-4.1 micrograms ml-1. Antiherpetic activity was directly correlated to the amount of alpha-D-galactose 2,6-disulfate residues in the natural carrageenans. The cyclization of the alpha-D-galactose 6-sulfate and 2,6-disulfate units into 3,6-anhydro-alpha-D-galactose and 3,6-anhydro-alpha-D-galactose 2-sulfate residues in these polysaccharides, in general, lowers the antiherpetic activity of the derivatives with respect to the natural carrageenans. Some carrageenans showed a very reduced anticoagulant activity only at concentrations that were considerably higher than the IC50, whereas others were totally devoid of anticoagulant properties. Among natural carrageenans, the mu/v-type IC3 shows the best relationship between antiviral efficacy and lack of anticoagulant action, resulting a very promising compound.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9184941     DOI: 10.1016/s0141-8130(96)01145-2

Source DB:  PubMed          Journal:  Int J Biol Macromol        ISSN: 0141-8130            Impact factor:   6.953


  31 in total

1.  In vitro anti-influenza virus activities of sulfated polysaccharide fractions from Gracilaria lemaneiformis.

Authors:  Mei-Zhen Chen; Hao-Gui Xie; La-Wei Yang; Zao-Hui Liao; Jie Yu
Journal:  Virol Sin       Date:  2010-10-08       Impact factor: 4.327

Review 2.  Role of Marine Natural Products in the Genesis of Antiviral Agents.

Authors:  Vedanjali Gogineni; Raymond F Schinazi; Mark T Hamann
Journal:  Chem Rev       Date:  2015-08-28       Impact factor: 60.622

3.  Immunomodulatory function of κ-carrageenan oligosaccharides acting on LPS-activated microglial cells.

Authors:  Zi-Ang Yao; Ling Xu; Hai-Ge Wu
Journal:  Neurochem Res       Date:  2013-12-20       Impact factor: 3.996

4.  Algae as promising organisms for environment and health.

Authors:  Emad A Shalaby
Journal:  Plant Signal Behav       Date:  2011-09

5.  Antiviral bioactivity of renewable polysaccharides against Varicella Zoster.

Authors:  Eiman Abu-Galiyun; Mahmoud Huleihel; Oshrat Levy-Ontman
Journal:  Cell Cycle       Date:  2019-11-14       Impact factor: 4.534

6.  ESI-MS differential fragmentation of positional isomers of sulfated oligosaccharides derived from carrageenans and agarans.

Authors:  Alan G Gonçalves; Diogo R B Ducatti; T Bruce Grindley; M Eugênia R Duarte; Miguel D Noseda
Journal:  J Am Soc Mass Spectrom       Date:  2010-04-07       Impact factor: 3.109

7.  Virucidal activity of polysaccharide extracts from four algal species against herpes simplex virus.

Authors:  Emma A Harden; Ruth Falshaw; Susan M Carnachan; Earl R Kern; Mark N Prichard
Journal:  Antiviral Res       Date:  2009-07-01       Impact factor: 5.970

Review 8.  The antiviral activities and mechanisms of marine polysaccharides: an overview.

Authors:  Wei Wang; Shi-Xin Wang; Hua-Shi Guan
Journal:  Mar Drugs       Date:  2012-12-12       Impact factor: 5.118

Review 9.  Recent Advances in Chemically-Modified and Hybrid Carrageenan-Based Platforms for Drug Delivery, Wound Healing, and Tissue Engineering.

Authors:  Hamidreza Mokhtari; Shima Tavakoli; Fereshteh Safarpour; Mahshid Kharaziha; Hamid Reza Bakhsheshi-Rad; Seeram Ramakrishna; Filippo Berto
Journal:  Polymers (Basel)       Date:  2021-05-26       Impact factor: 4.329

Review 10.  The antiviral activity of iota-, kappa-, and lambda-carrageenan against COVID-19: A critical review.

Authors:  Andri Frediansyah
Journal:  Clin Epidemiol Glob Health       Date:  2021-06-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.